BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3793150)

  • 1. [A case of disseminated miliary lupus of the face treated with dapsone].
    Barone M; Antonelli C; De Padova MP; Bardazzi F; Labanca M
    G Ital Dermatol Venereol; 1986; 121(5):375-6. PubMed ID: 3793150
    [No Abstract]   [Full Text] [Related]  

  • 2. Guess what? Linear cutaneous lupus erythematous (LCLE): relationship with Blaschko's lines.
    Abe M; Ohnishi K; Ishikawa O
    Eur J Dermatol; 2000; 10(3):229-31. PubMed ID: 10896467
    [No Abstract]   [Full Text] [Related]  

  • 3. Nosology and therapeutic options for lupus miliaris disseminatus faciei.
    Al-Mutairi N
    J Dermatol; 2011 Sep; 38(9):864-73. PubMed ID: 21714812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine.
    Pinto-Almeida T; Sanches M; Alves R; Selores M
    Dermatol Online J; 2012 Aug; 18(8):13. PubMed ID: 22948063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study.
    Tzung TY; Liu YS; Chang HW
    Br J Dermatol; 2007 Jan; 156(1):191-2. PubMed ID: 17199600
    [No Abstract]   [Full Text] [Related]  

  • 6. Annular subacute cutaneous lupus erythematosus responsive to dapsone.
    McCormack LS; Elgart ML; Turner ML
    J Am Acad Dermatol; 1984 Sep; 11(3):397-401. PubMed ID: 6480948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous systemic lupus erythematosus in a child responding to dapsone.
    Liu KL; Shen JL; Yang CS; Chen YJ
    Pediatr Dermatol; 2014; 31(4):e104-6. PubMed ID: 24846529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular triamcinolone acetonide for lupus miliaris disseminatus faciei.
    Tokunaga H; Okuyama R; Tagami H; Aiba S
    Acta Derm Venereol; 2007; 87(5):451-2. PubMed ID: 17721664
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus.
    von Pelchrzim R; Schmook T; Friedrich M; Worm M
    Int J Dermatol; 2006 Jan; 45(1):84-5. PubMed ID: 16426386
    [No Abstract]   [Full Text] [Related]  

  • 10. Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
    Holtman JH; Neustadt DH; Klein J; Callen JP
    J Rheumatol; 1990 Sep; 17(9):1222-5. PubMed ID: 2290166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone as Second-Line Treatment for Cutaneous Lupus Erythematosus? A Retrospective Analysis of 34 Patients and a Review of the Literature.
    Klebes M; Wutte N; Aberer E
    Dermatology; 2016; 232(1):91-6. PubMed ID: 26606129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pimecrolimus 1% cream for cutaneous lupus erythematosus.
    Kreuter A; Gambichler T; Breuckmann F; Pawlak FM; Stücker M; Bader A; Altmeyer P; Freitag M
    J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of 35 cases of lupus miliaris disseminatus faciei.
    Amîruddîn D; Mii S; Fujimura T; Katsuoka K
    J Dermatol; 2011 Jun; 38(6):618-20. PubMed ID: 21352284
    [No Abstract]   [Full Text] [Related]  

  • 14. Dapsone syndrome in cutaneous lupus erythematosus.
    Mok CC; Lau CS
    J Rheumatol; 1996 Apr; 23(4):766-8. PubMed ID: 8730143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone: an old drug effective for subacute cutaneous lupus erythematosus.
    Zampeli E; Moutsopoulos HM
    Rheumatology (Oxford); 2019 May; 58(5):920-921. PubMed ID: 30615176
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.
    Yoshimasu T; Ohtani T; Sakamoto T; Oshima A; Furukawa F
    Eur J Dermatol; 2002; 12(1):50-2. PubMed ID: 11809595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to hydroxychloroquine due to smoking in a patient with lupus erythematosus tumidus.
    Hügel R; Schwarz T; Gläser R
    Br J Dermatol; 2007 Nov; 157(5):1081-3. PubMed ID: 17854374
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dapsone efficacy in lupus miliaris disseminatus faciei: two cases].
    El Benaye J; Oumakhir S; Ghfir M; Sedrati O
    Ann Dermatol Venereol; 2011; 138(8-9):597-600. PubMed ID: 21893234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus miliaris disseminatus faciei: treatment with the 1450-nm diode laser.
    Jih MH; Friedman PM; Kimyai-Asadi A; Friedman ES; Hymes SR; Goldberg LH
    Arch Dermatol; 2005 Feb; 141(2):143-5. PubMed ID: 15724009
    [No Abstract]   [Full Text] [Related]  

  • 20. Bullous systemic lupus erythematosus: response to dapsone in two patients.
    Sirka CS; Padhi T; Mohanty P; Patel DK; Parida PR; Kar CR
    Indian J Dermatol Venereol Leprol; 2005; 71(1):54-6. PubMed ID: 16394370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.